Marinus Pharmaceuticals Inc. (MRNS)

4.29
NASDAQ : Health Technology
Prev Close 4.22
Day Low/High 4.09 / 4.31
52 Wk Low/High 2.36 / 10.54
Avg Volume 565.90K
Exchange NASDAQ
Shares Outstanding 52.55M
Market Cap 221.78M
EPS -0.90
P/E Ratio N/A
Div & Yield N.A. (N.A)

Latest News

Marinus Pharmaceuticals (MRNS) Shares Cross Above 200 DMA

Marinus Pharmaceuticals (MRNS) Shares Cross Above 200 DMA

In trading on Monday, shares of Marinus Pharmaceuticals Inc crossed above their 200 day moving average of $5.11, changing hands as high as $5.34 per share. Marinus Pharmaceuticals Inc shares are currently trading up about 8.5% on the day.

First Week Of June 21st Options Trading For Marinus Pharmaceuticals (MRNS)

First Week Of June 21st Options Trading For Marinus Pharmaceuticals (MRNS)

Investors in Marinus Pharmaceuticals Inc saw new options become available this week, for the June 21st expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRNS options chain for the new June 21st contracts and identified one put and one call contract of particular interest.

Interesting MRNS Put And Call Options For January 2021

Interesting MRNS Put And Call Options For January 2021

Investors in Marinus Pharmaceuticals Inc saw new options become available today, for the January 2021 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 730 days until expiration the newly available contracts represent a potential opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

First Week Of February 15th Options Trading For Marinus Pharmaceuticals (MRNS)

First Week Of February 15th Options Trading For Marinus Pharmaceuticals (MRNS)

Investors in Marinus Pharmaceuticals Inc saw new options become available this week, for the February 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRNS options chain for the new February 15th contracts and identified one put and one call contract of particular interest.

First Week Of July 2019 Options Trading For Marinus Pharmaceuticals (MRNS)

First Week Of July 2019 Options Trading For Marinus Pharmaceuticals (MRNS)

Investors in Marinus Pharmaceuticals Inc saw new options become available this week, for the July 2019 expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 234 days until expiration the newly available contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Notable Wednesday Option Activity: MRNS, HTLD, LEA

Notable Wednesday Option Activity: MRNS, HTLD, LEA

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Marinus Pharmaceuticals Inc , where a total volume of 8,315 contracts has been traded thus far today, a contract volume which is representative of approximately 831,500 underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 86.7% of MRNS's average daily trading volume over the past month, of 958,695 shares.

Interesting MRNS Put And Call Options For December 21st

Interesting MRNS Put And Call Options For December 21st

Investors in Marinus Pharmaceuticals Inc saw new options begin trading today, for the December 21st expiration. One of the key data points that goes into the price an option buyer is willing to pay, is the time value, so with 94 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

Marinus Pharmaceuticals Is Now Oversold

Marinus Pharmaceuticals Is Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

MRNS Makes Notable Cross Below Critical Moving Average

MRNS Makes Notable Cross Below Critical Moving Average

In trading on Thursday, shares of Marinus Pharmaceuticals Inc crossed below their 200 day moving average of $6.23, changing hands as low as $5.62 per share. Marinus Pharmaceuticals Inc shares are currently trading down about 9.2% on the day.

Notable Tuesday Option Activity: MRNS, PGNX, MB

Notable Tuesday Option Activity: MRNS, PGNX, MB

Looking at options trading activity among components of the Russell 3000 index, there is noteworthy activity today in Marinus Pharmaceuticals Inc , where a total volume of 15,724 contracts has been traded thus far today, a contract volume which is representative of approximately 1.6 million underlying shares (given that every 1 contract represents 100 underlying shares). That number works out to 275% of MRNS's average daily trading volume over the past month, of 571,815 shares.

Pfizer Doesn't Look Fundamentally or Technically Strong

Pfizer Doesn't Look Fundamentally or Technically Strong

The stock faces a lot of headwinds on a day when markets are trying to surmount trade-war woes.

First Week Of MRNS August 17th Options Trading

First Week Of MRNS August 17th Options Trading

Investors in Marinus Pharmaceuticals Inc saw new options become available this week, for the August 17th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRNS options chain for the new August 17th contracts and identified one put and one call contract of particular interest.

Marinus Pharmaceuticals Breaks Above 200-Day Moving Average - Bullish For MRNS

In trading on Thursday, shares of Marinus Pharmaceuticals Inc crossed above their 200 day moving average of $5.49, changing hands as high as $6.19 per share. Marinus Pharmaceuticals Inc shares are currently trading up about 5.7% on the day.

RSI Alert: Marinus Pharmaceuticals (MRNS) Now Oversold

RSI Alert: Marinus Pharmaceuticals (MRNS) Now Oversold

Legendary investor Warren Buffett advises to be fearful when others are greedy, and be greedy when others are fearful. One way we can try to measure the level of fear in a given stock is through a technical analysis indicator called the Relative Strength Index, or RSI, which measures momentum on a scale of zero to 100.

Interesting MRNS Put And Call Options For October 19th

Interesting MRNS Put And Call Options For October 19th

Investors in Marinus Pharmaceuticals Inc saw new options begin trading this week, for the October 19th expiration. One of the key inputs that goes into the price an option buyer is willing to pay, is the time value, so with 238 days until expiration the newly trading contracts represent a possible opportunity for sellers of puts or calls to achieve a higher premium than would be available for the contracts with a closer expiration.

First Week of February 2018 Options Trading For Marinus Pharmaceuticals (MRNS)

First Week of February 2018 Options Trading For Marinus Pharmaceuticals (MRNS)

Investors in Marinus Pharmaceuticals Inc saw new options become available this week, for the February 2018 expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRNS options chain for the new February 2018 contracts and identified one put and one call contract of particular interest.

First Week of MRNS December 15th Options Trading

First Week of MRNS December 15th Options Trading

Investors in Marinus Pharmaceuticals Inc saw new options become available this week, for the December 15th expiration. At Stock Options Channel, our YieldBoost formula has looked up and down the MRNS options chain for the new December 15th contracts and identified one put and one call contract of particular interest.

Leaders Are Lagging and Laggers Are Leading

Leaders Are Lagging and Laggers Are Leading

We are seeing some weird market action, this morning.